SEC Form D · filed August 5, 2021
Indaptus Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Michael J. Newman · NEW YORK, NYExec · DirectorNir A. Sassi · NEW YORK, NYExecWilliam B. Hayes · NEW YORK, NYDirectorWalt A. Linscott · NEW YORK, NYExecAnthony J. Maddaluna · NEW YORK, NYDirectorJeffrey A. Meckler · NEW YORK, NYExec · DirectorHila J. Karah · NEW YORK, NYDirectorRoger J. Pomerantz · NEW YORK, NYDirectorHoonmo A. Lee · NEW YORK, NYDirectorBrian J. O'Callaghan · San Diego, CADirectorHoonmo A. Lee · NEW YORK, NYDirectorBrian J. O'Callaghan · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗